Haemonetics Corp (HAE) Live Share Price, Invest From India

Haemonetics Corp Stock Performance

as on March 20, 2026 at 6:59 am IST

Day's Low
Day's High
$58.86
Day's Price Range
$60.93
$58.96
0.17%
Downside
3.34%
Upside
52 Week's Low
52 Week's High
$47.32
52-Week Price Range
$87.32
$58.96
19.75%
Downside
48.10%
Upside

Haemonetics Corp share price movements today

Previous Close: $59.52
Open: $59.72
Volume: 283.2K
Day's Low - High: $58.86 - $60.93
52 Week Low - High: $47.32 - $87.32

Haemonetics Corp Historical Returns

1 Month Return: -1.9 %
3 Month Return: -25.79 %
1 Year Return: -8.75 %
3 Year Return: -22.31 %
5 Year Return: -47.76 %

Haemonetics Corp Stock Fundamentals & Key Indicators

Check Haemonetics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8B

EPS (TTM)

4.9465

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.28%

PE Ratio (TTM)

16.54

Industry PE ratio

7.871681415929204

PEG Ratio

0.9128

EBITDA

364.9M

Revenue (TTM)

1.3B

Profit Margin

13.31%

Return On Equity TTM

19.30%

Haemonetics Corp Stock Valuation

Track how Haemonetics Corp P/E has moved over time to understand its valuation trends.

Haemonetics Corp in the last 5 years

Overview
Trends

Lowest (12.90x)

September 30, 2025

Industry (7.87x)

March 19, 2026

Today (16.54x)

March 19, 2026

Highest (52.66x)

March 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 16.54x

Haemonetics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Haemonetics Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Haemonetics Corp	BUY	$2.8B	-47.76%	16.54	13.31%
Boston Scientific Corp.	BUY	$105.7B	86.74%	36.7	14.44%
Stryker Corporation	BUY	$133.6B	50.35%	41.51	12.92%
Abbott Laboratories	BUY	$192.4B	-9.78%	29.76	14.72%
Medtronic Plc	BUY	$113.5B	-25.22%	24.7	13.00%

See all

Stock Returns calculator for Haemonetics Corp Stock including INR - Dollar returns

The Haemonetics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Haemonetics Corp investment value today

Current value as on today

₹98,350

Returns

₹1,650

(-1.65%)

Returns from Haemonetics Corp Stock

₹9,612 (-9.61%)

Dollar Returns*

₹7,962 (+7.96%)

Analyst Recommendation on Haemonetics Corp Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Haemonetics Corp. Average target price of $87.5

Haemonetics Corp Share Price Target

Get share price movements and forecasts by analysts on Haemonetics Corp.

What analysts predicted

32.62%UPSIDE

Target Price

$87.5

Current Price

$58.96

Analyzed by

11 Analysts

Target

$87.50

Haemonetics Corp target price $87.5, a slight upside of 32.62% compared to current price of $58.96. According to 11 analysts rating.

Haemonetics Corp Stock’s Investor Sentiment and Interest

Search interest for Haemonetics Corp Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 18, 2026 to March 20, 2026

Change:-43% versus previous 30 day period

Haemonetics Corp Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	318	336	343	336	345	348	330	321	327	338
Gross Profit	170	184	188	179	191	199	193	191	194	191
Operating Income	35	45	29	39	51	59	71	53	58	69
EBITDA	65	82	68	80	88	95	99	93	86	95
Interest Expense	2	1	6	6	6	9	0	4	7	8
Depreciation	7	23	27	29	29	29	28	28	28	27
Income Before Tax	32	44	23	46	44	49	70	45	51	59
Income Tax Expense	7	12	3	8	10	12	12	11	12	15
Net Income	24	31	20	38	33	37	57	34	38	44
Net Profit Margin	7.83%	9.29%	5.93%	11.41%	9.79%	10.76%	17.54%	10.59%	11.82%	13.20%

Haemonetics Corp Annual Profit & Loss

All numbers in Millions USD

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Revenue	908	886	903	967	988	870	993	1,168	1,309	1,360
Gross Profit	405	378	411	417	487	428	530	622	711	778
Operating Income	-43	-19	56	83	103	89	80	156	164	221
EBITDA	128	123	153	192	257	184	191	252	295	355
Interest Expense	9	8	4	9	16	16	17	14	13	9
Depreciation	-	-	89	109	110	84	97	93	97	115
Income Before Tax	-53	-27	59	73	87	72	63	141	151	212
Income Tax Expense	2	-1	14	18	10	-6	20	26	34	44
Net Income	-55	-26	45	55	76	79	43	115	117	167
Net Profit Margin	-6.12%	-2.96%	5.04%	5.69%	7.74%	9.13%	4.37%	9.87%	8.98%	12.32%

Haemonetics Corp Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	31	20	38	33	37	57	34	38	44
Operating Cash Flow	0	64	-27	48	43	116	17	111	93
Investing Cash Flow	-268	-13	-139	-23	-17	18	-33	-30	-29
Financing Cash Flow	109	-63	333	-74	1	-151	-2	-76	2
Change in Cash	-157	-15	165	-45	21	-14	-13	3	66

Haemonetics Corp Annual Cash Flow

All numbers in Millions USD

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Income	-26	45	55	76	79	43	115	117	167
Operating Cash Flow	159	220	159	158	108	172	273	181	181
Investing Cash Flow	-73	-63	-116	-57	-425	-86	-143	-322	-161
Financing Cash Flow	-60	-120	-50	-131	367	-15	-100	38	108
Change in Cash	24	40	-10	-32	54	67	24	-105	127

Global Institutional Holdings in Haemonetics Corp

Funds	Holdings
Schroder Investment Management Group	1.85%
State Street Corp	3.87%
Arrowstreet Capital Limited Partnership	2.97%
Wellington Management Company LLP	4.46%
Dimensional Fund Advisors, Inc.	2.35%

See all

Haemonetics Corp News & Key Events

Insights on Haemonetics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 321.39M → 338.96M (in $), with an average increase of 2.6% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 34.03M → 44.74M (in $), with an average increase of 12.8% per quarter
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 16.5% return, outperforming this stock by 25.3%
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 2.3% return, outperforming this stock by 24.6%
NEGATIVE IMPACT
Price Dip
In the last 3 months, HAE stock has moved down by -25.8%

About Haemonetics Corp

haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right

Organisation	Haemonetics Corp
Headquarters	125 Summer Street, Boston, MA, United States, 02110
Industry	Health Technology
CEO	Mr. Christopher A. Simon
E-voting on shares	Click here to vote

Key Management of Haemonetics Corp

Name	Title
Mr. James C. D'Arecca CPA	CFO, Executive VP & Financial Officer
Ms. Farris Maryanne Maunsell	VP, Chief Accounting Officer & Principal Accounting Officer
Mr. Rajeev Varma	Senior Vice President of Strategy & Corporate Development
Ms. Olga Guyette	Senior Director of Investor Relations
Ms. Laurie A. Miller	Senior VP & Chief Human Resources Officer
Dr. Jan Hartmann M.D.	Senior VP & Chief Medical Officer
Mr. Christopher A. Simon	CEO, President & Director
Ms. Michelle L. Basil Esq., J.D.	Executive VP, General Counsel & Secretary
Mr. Roy Galvin	Executive VP & Chief Commercial Officer
Mr. Frank W. Chan Ph.D.	Executive VP & COO

FAQs

What is Haemonetics Corp share price today?

Haemonetics Corp share price today is $58.96 as on March 20, 2026 at 1:29 am IST at the close of the market. Haemonetics Corp share today touched a day high of $60.93 and a low of $58.86.

What is the 52 week high and 52 week low for Haemonetics Corp share?

Haemonetics Corp share touched a 52 week high of $87.32 on December 10, 2025 and a 52 week low of $47.32 on September 26, 2025. Haemonetics Corp stock price today i.e. March 20, 2026 at 1:29 am IST is closed at $58.96,which is 32.48% down from its 52 week high and 24.61% up from its 52 week low.

What is Haemonetics Corp's market capitalisation today?

Haemonetics Corp market capitalisation is $0.00T as on March 20, 2026 at 1:29 am IST.

How to invest in Haemonetics Corp Stock (HAE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Haemonetics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Haemonetics Corp Shares that will get you 0.0254 shares as per Haemonetics Corp share price of $58.96 per share as on March 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Haemonetics Corp Stock (HAE) from India?

Indian investors can start investing in Haemonetics Corp (HAE) shares with as little as ₹93.193 or $1 (as of March 20, 2026 at 5:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹931.93 in Haemonetics Corp stock (as per the Rupee-Dollar exchange rate as on March 20, 2026 at 5:38 am IST). Based on Haemonetics Corp share’s latest price of $58.96 as on March 20, 2026 at 1:29 am IST, you will get 0.1696 shares of Haemonetics Corp. Learn more about fractional shares .

What are the returns that Haemonetics Corp has given to Indian investors in the last 5 years?

Haemonetics Corp stock has given -47.76% share price returns and 27.41% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?